Spots Global Cancer Trial Database for epithelial ovarian
Every month we try and update this database with for epithelial ovarian cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma) | NCT02485990 | Primary Periton... | Tremelimumab Olaparib | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer | NCT06173037 | Primary Periton... Fallopian Tube Epithelial Ovar... | RC88 | 18 Years - | RemeGen Co., Ltd. | |
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment | NCT00421889 | Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Bladder Cancer | belinostat Paclitaxel Carboplatin | 18 Years - | Valerio Therapeutics | |
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | NCT00501644 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Carboplatin GM-CSF (Sargram... Interferon Gamm... | - | M.D. Anderson Cancer Center | |
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment | NCT00421889 | Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Bladder Cancer | belinostat Paclitaxel Carboplatin | 18 Years - | Valerio Therapeutics | |
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma | NCT00407407 | Fallopian Tube ... Peritoneal Neop... Ovarian Neoplas... | ABI-007 Carboplatin | 18 Years - | Celgene | |
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | NCT00501644 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Carboplatin GM-CSF (Sargram... Interferon Gamm... | - | M.D. Anderson Cancer Center | |
Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma) | NCT02485990 | Primary Periton... | Tremelimumab Olaparib | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer | NCT06173037 | Primary Periton... Fallopian Tube Epithelial Ovar... | RC88 | 18 Years - | RemeGen Co., Ltd. |